Skip to main content
. 2022 Sep 11;14(18):4410. doi: 10.3390/cancers14184410

Figure 3.

Figure 3

Kaplan–Meier curves for relapse-free survival of cutaneous melanoma patients and thirds of the pan-immune inflammation value (PIV, (A): 1st third-PIV ≤ 219.73; 2nd third-PIV > 219.73 to 393.73; 3rd third-PIV > 393.73) and the neutrophil-to-lymphocyte ratio (NLR, B): 1st third-NLR ≤ 2.02; 2nd third-NLR > 2.02 to 3; 3rd third-NLR > 3). 3rd thirds of PIV (A) and NLR (B) appear to be associated with poorer relapse-free survival (hazard ratio: 1.718, 95% CI 1.143 to 2.584 and hazard ratio: 1.702, 95% CI 1.104 to 2.623, respectively).